Half of HIV-positive gay men disagree that HIV treatment makes you less infectious

Gus Cairns
Published: 15 November 2012

A survey of over 2000 gay men attending clinics in the UK has found that 48% disagree that HIV treatment can make someone less infectious or makes it unnecessary to use a condom, the eleventh International Congress on Drug Therapy in HIV Infection in Glasgow heard this week.

Although the ASTRA (Antiretrovirals, Sexual Transmission Risk and Attitudes) survey found that only 15% of men had recently had unprotected sex with someone of negative or unknown HIV status (serodiscordant unprotected anal intercourse or sdUAI), it discovered that that the minority of men who were not taking antiretroviral therapy (ART) were actually rather more, rather than less, likely to have unprotected sex with a partner of negative or unknown HIV status than men taking ART.

However, in gay men who were taking ART, those with a detectable viral load were considerably less likely to have sdUAI than men with an undetectable viral load, suggesting some men are taking their viral load into account when making decisions about unprotected sex.

The survey also found that beliefs about viral load and infectiousness did have an influence on safer-sex decisions, with men who did not believe that viral load reduces infectiousness being less than half as likely to have sdUAI as men who believed that it did.

Study details

For this study, questions answered by 2086 men out of over 3000 answered in the last year were analysed. Their average age was 43, 88% were white and 85% were on ART. Of these 83% had an undetectable viral load, so over 70% of the whole group had an undetectable viral load on treatment. Just over 8% of men knew they had a detectable viral load and the same proportion did not know their viral load.

The men were asked whether they agreed with two statements: “When a viral load is undetectable, condoms are not needed to prevent HIV transmission” and “Undetectable viral load makes someone less infectious to a sexual partner”. Only 4% agreed with the first statement; 48% agreed with the second, leaving another 48% who agreed with neither.

Just under two-thirds of the men (64%) had had any anal intercourse in the last three months, and 37% had had any unprotected sex, but over half of these only had unprotected sex with another positive partner or partners. This means that 15% had sdUAI: of these 40% only took the receptive role when they had unprotected sex, indicating some ‘seropositioning’ behaviour, while 20% only had sdUAI with one regular partner.

Serodiscordant UAI was actually rather more common in men who were not on ART: 20% (3% of the whole group) were not on ART but had sdUAI, while 14% of men on ART (12% of the whole group) had sdUAI. Thus men off ART were 25% more likely to have sdUAI then men on it, and this was statistically significant (p=0.006). However, only 9.4% of men who were on ART but did not have an undetectable viral load had sdUAI, so if men were on ART, they were 40% less likely to have sdUAI than if they were detectable.

One reason men not taking ART might have more unprotected sex is because sdUAI was high in men who had only recently been diagnosed: 23% of men diagnosed within the last three months had sdUAI, but more than three months after diagnosis this had reverted to 14%. Young people (who might be more recently diagnosed and less likely to be on ART) were also more likely to have sdUAI: 24% did so.

Other factors associated with sdUAI were recreational drug use, which more than doubled the likelihood of sdUAI, and alcohol, which increased it by 50%; men with hepatitis C were also 50% more likely to have sdUAI, though this may be effect rather than cause. Ethnicity, employment, education, smoking and CD4 count were not associated with sdUAI and importantly, in this study at least, depression was not associated with it.

The chance of having sdUAI increased with the number of partners men had. While 39% of men had not sex in the last year, one in eight had had more than 20 partners and 4.4% more than 50. Amongst these latter groups, respectively a third and nearly a half had had sdUAI in the last three months.

These findings obviously have, as the researchers comment, implications for prevention strategies in the UK, particularly in terms of the complex question of whether making people aware of the benefits of treatment as prevention may have the effect of increasing risk behaviour.


Lampe F et al. ART use, viral suppression and sexual behaviour among HIV-diagnosed MSM in the UK: results from the antiretrovirals, sexual transmission risk and attitudes (ASTRA) study. Eleventh International Congress on Drug Therapy in HIV Infection, Glasgow, abstract O323, 2012. View abstract here.


United Kingdom

Find details of HIV services in United Kingdom, the latest news from the country, and a selection of resources from local organisations.

Find out more about United Kingdom >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.